To additionally validate these results, we also evaluated the native IRS2 protein and its phosphoprotein in a panel of tumor cell lines by using an antibody specific for the phosphorylated IRS2 protein (against pSer1100), as well as an antibody that recognizes total IRS2 protein. Here, IRS2 is linked to neoplasm.